New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
06:57 EDTZFGNZafgen initiated with an Outperform at JMP Securities
Target $31.
News For ZFGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 23, 2015
10:02 EDTZFGNOn the Fly: Analyst Initiation Summary
Subscribe for More Information
07:06 EDTZFGNZafgen 3.94M share Secondary priced at $35.00
Leerink Partners LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering. Canaccord Genuity, Inc. and JMP Securities LLC are acting as co-managers.
January 22, 2015
16:16 EDTZFGNZafgen initiated with an Outperform at RBC Capital
07:52 EDTZFGNZafgen drug shows promise for children with rare weight disorder, NY Times says
Prader-­Willi syndrome, which is marked by children having morbid obesity, low muscle tone and other developmental issues, is being studied by pharmaceutical companies including Zafgen, reported The New York Times. The company's drug, beloranib, seemed in a small pilot study to reduce weight, body fat and, for the first time, insatiability in Prader-­Willi subjects and the company has moved on to larger trials, the report noted. Reference Link
January 12, 2015
06:14 EDTZFGNZafgen files to sell 2.5M shares of common stock
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use